Jan 30, 2026
1:12
For every 12 shares held, investors received 1. The price per share adjusted from $0.97 to $0.08.
The split itself did not change the total investment value.
Satellos Bioscience Inc. (MSCLF) trades on the Other OTC in the Biotechnology industry.
Satellos Bioscience Inc. company overviewThe latest split shown was on January 30, 2026. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
This history records 2 reverse splits between August 18, 2021 and January 30, 2026.
Already premium?